Literature DB >> 19734086

Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo.

Susan E Tomlinson1, Michael G Hanna, Dimitri M Kullmann, S Veronica Tan, David Burke.   

Abstract

Clinical neurophysiology has become an invaluable tool in the diagnosis of muscle channelopathies, but the situation is less clear cut with neuronal channelopathies. The genetic episodic ataxias are a group of disorders with heterogeneous phenotype and genotype, but share in common the feature of intermittent cerebellar dysfunction. Episodic ataxia (EA) types 1 and 2 are the most widely recognised of the autosomal dominant episodic ataxias and are caused by dysfunction of neuronal voltage-gated ion channels. There are central and peripheral nervous system manifestations in both conditions, and they are therefore good models of neuronal channelopathies to study neurophysiologically. To date most work has focussed upon characterising the electrophysiological properties of mutant channels in vitro. This review summarises the role of voltage-gated potassium and calcium channels, mutations of which underlie the main types of episodic ataxia types 1 and 2. The clinical, genetic and electrophysiological features of EA1 and EA2 are outlined, and a protocol for the assessment of these patients is proposed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734086     DOI: 10.1016/j.clinph.2009.07.003

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  16 in total

Review 1.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

2.  Novel CACNA1A mutation(s) associated with slow saccade velocities.

Authors:  Stefan Kipfer; Simon Jung; Johannes R Lemke; Anna Kipfer-Kauer; Jeremy P Howell; Alain Kaelin-Lang; Thomas Nyffeler; Klemens Gutbrod; Angela Abicht; René M Müri
Journal:  J Neurol       Date:  2013-09-18       Impact factor: 4.849

3.  The first knockin mouse model of episodic ataxia type 2.

Authors:  Samuel J Rose; Lisa H Kriener; Ann K Heinzer; Xueliang Fan; Robert S Raike; Arn M J M van den Maagdenberg; Ellen J Hess
Journal:  Exp Neurol       Date:  2014-08-08       Impact factor: 5.330

4.  Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.

Authors:  Susan E Tomlinson; S Veronica Tan; Dimitri M Kullmann; Robert C Griggs; David Burke; Michael G Hanna; Hugh Bostock
Journal:  Brain       Date:  2010-11-23       Impact factor: 13.501

5.  A canine BCAN microdeletion associated with episodic falling syndrome.

Authors:  Jennifer L Gill; Kate L Tsai; Christa Krey; Rooksana E Noorai; Jean-François Vanbellinghen; Laurent S Garosi; G Diane Shelton; Leigh Anne Clark; Robert J Harvey
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

6.  In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2.

Authors:  Susan E Tomlinson; S Veronica Tan; David Burke; Robyn W Labrum; Andrea Haworth; Vaneesha S Gibbons; Mary G Sweeney; Robert C Griggs; Dimitri M Kullmann; Hugh Bostock; Michael G Hanna
Journal:  Brain       Date:  2016-02       Impact factor: 13.501

7.  In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission.

Authors:  Susan E Tomlinson; Hugh Bostock; Bronwyn Grinton; Michael G Hanna; Dimitri M Kullmann; Matthew C Kiernan; Ingrid E Scheffer; Samuel F Berkovic; David Burke
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

8.  Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome.

Authors:  J Helen Cross; Ruchi Arora; Rolf A Heckemann; Roxana Gunny; Kling Chong; Lucinda Carr; Torsten Baldeweg; Ann-Marie Differ; Nicholas Lench; Sophie Varadkar; Tony Sirimanna; Evangeline Wassmer; Sally A Hulton; Milos Ognjanovic; Venkateswaran Ramesh; Sally Feather; Robert Kleta; Alexander Hammers; Detlef Bockenhauer
Journal:  Dev Med Child Neurol       Date:  2013-09       Impact factor: 5.449

9.  The episodic ataxia type 1 mutation I262T alters voltage-dependent gating and disrupts protein biosynthesis of human Kv1.1 potassium channels.

Authors:  Szu-Han Chen; Ssu-Ju Fu; Jing-Jia Huang; Chih-Yung Tang
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379

10.  Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.

Authors:  Susan Elizabeth Tomlinson; Sanjeev Rajakulendran; Stella Veronica Tan; Tracey Dawn Graves; Doris-Eva Bamiou; Robyn W Labrum; David Burke; Carolyn M Sue; Paola Giunti; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-24       Impact factor: 13.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.